Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized shares, including placement through the ATM, over the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results